Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...

STOK, the landmark 60,000 sq ft office building in Stockport, has completed the fit out of its final phase of 'plug and play' ...

Wrexham have taken a significant step toward boosting their stadium’s capacity, having officially submitted a planning ...

Located near Openshaw Park and close to key amenities, the development offers a mix of two-bedroom apartments and ...

Liberato Cacace has watched every episode of Welcome to Wrexham - now he himself will feature in the Disney+ documentary.

Stoke Therapeutics (STOK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Wrexham's women now have a long-term permanent home after the club completed the purchase of The Rock in Rhosymedre.

The market expects Stoke Therapeutics, Inc. (STOK) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known ...

School Bus Manufacturers Stay the Course Despite Regulatory, Funding Uncertainty School Transportation News News ...

Fintel reports that on July 18, 2025, Jefferies initiated coverage of Stoke Therapeutics (NasdaqGS:STOK) with a Buy recommendation. Analyst Price Forecast Suggests 84.80% Upside As of July 17, 2025, ...

The maker of Dannon yogurt sued rival Chobani on Tuesday for allegedly copying its "Bright & Mellow" slogan and ...